Antineoplaston Therapy in Treating Patients With Primary Liver Cancer

Stopped early · Phase 2

Conditions studied: Primary Liver Cancer

In brief

Current therapies for Primary Liver Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Primary Liver Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with advanced Head and Neck Cancer.

Key facts

Study ID

NCT00003530

Run by

Burzynski Research Institute

People needed

3

Starts

1977-03-21

Expected to finish

1999-10-17

Last updated by the study team

2017-11-21

Who can join

Age: 14 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Burzynski Clinic — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.